Japanese drugmaker Astellas Pharma says it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labor ...

(RTTNews) - Astellas Pharma Inc. (ALPMY) Wednesday announced the submission of a New Drug Application or NDA in Japan for Conditional Approval of Avacincaptad Pegol intravitreal solution or ACP for ...

The Indian Army will soon close the online application for the Short Service Commission (Tech) men 65th course (Oct 2025) and ...

NEW YORK, NY / ACCESS Newswire / February 5, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want ...

Astellas Pharma Inc. (TSE: 4503) (President and CEO: Naoki Okamura, "Astellas") today announced the submission of a New Drug Application (NDA) to Japan's Ministry of Health, Labour and Welfare (MHLW) ...

Stay tuned to Republic for the latest updates on India news, today's headlines, and breaking news from Delhi. Get real-time ...

Eton Pharma gets US patent covering its ET-600 product candidate’s proprietary formulation of desmopressin oral solution: Deer Park, Illinois Monday, February 10, 2025, 11:00 Hr ...

The Edo State Governorship Election Petition Tribunal sitting in Abuja, on Thursday, adjourned proceedings to Monday, ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Kirby McInerney LLP Alerts Applied Therapeutics, Inc. Investors of Important Lead Plaintiff Deadline in Class Action Lawsuit ...

Kirby McInerney LLP Urges Investors in Applied Therapeutics, Inc. (APLT) to Inquire About Their Rights in Class Action Lawsuit. Tweet ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for ...